Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Inhibition of cell cycle progression by dual phosphatidylinositol-3-kinase and mTOR blockade in cyclin D2 positive multiple myeloma bearing IgH translocations.

Glassford J, Kassen D, Quinn J, Stengel C, Kallinikou K, Khwaja A, Yong KL.

Blood Cancer J. 2012 Jan;2(1):e50. doi: 10.1038/bcj.2011.44. Epub 2012 Jan 13.

PMID:
22829234
[PubMed]
Free PMC Article
2.

Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma.

Bergsagel PL, Kuehl WM.

Immunol Rev. 2003 Aug;194:96-104. Review.

PMID:
12846810
[PubMed - indexed for MEDLINE]
3.

Molecular pathogenesis and a consequent classification of multiple myeloma.

Bergsagel PL, Kuehl WM.

J Clin Oncol. 2005 Sep 10;23(26):6333-8. Review.

PMID:
16155016
[PubMed - indexed for MEDLINE]
Free Article
4.

Advances in biology of multiple myeloma: clinical applications.

Hideshima T, Bergsagel PL, Kuehl WM, Anderson KC.

Blood. 2004 Aug 1;104(3):607-18. Epub 2004 Apr 15. Review.

PMID:
15090448
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk